nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Comparative Study of Internet Search Engines by Applying “Cost Effective Treatment for Myocardial Infarction” as a Search Topic
|
Akaho, Eiichi |
|
|
32 |
4 |
p. 921-932 |
artikel |
2 |
A Data Model for Clinical Study Status Reports
|
Christiansen, David H. |
|
|
32 |
4 |
p. 887-895 |
artikel |
3 |
Adoption of New Pharmacotherapeutic Regimens: Analysis of Physician Prescribing for Peptic Ulcer Disease
|
Ray, Nancy Fox |
|
|
32 |
4 |
p. 1119-1131 |
artikel |
4 |
An Overview of Knowledge Integration for Innovation in Healthcare and Pharmaceuticals
|
Abbott, Robert |
|
|
32 |
4 |
p. 905-915 |
artikel |
5 |
A Primer on CBER’s Regulatory Review Structure and Process
|
Sensabaugh, Suzanne M. |
|
|
32 |
4 |
p. 1011-1030 |
artikel |
6 |
Assembling International Regulatory Submissions: A Simplified Approach
|
Rhorer, Robert G. |
|
|
32 |
4 |
p. 1169-1171 |
artikel |
7 |
Auditing New Electronic Systems
|
Stinchcomb, William B. |
|
|
32 |
4 |
p. 1073-1080 |
artikel |
8 |
Balancing Phase II and III Efficacy Trials
|
Sandage, Bobby W. |
|
|
32 |
4 |
p. 977-980 |
artikel |
9 |
Being Inspected: What is It Like?
|
Culter, Neal R. |
|
|
32 |
4 |
p. 1043-1047 |
artikel |
10 |
CBER’s New Managed Review Process: A Managed and Integrated Regulatory Process which is Continuous from Discovery to Post Marketing
|
Sensabaugh, Suzanne M. |
|
|
32 |
4 |
p. 1031-1041 |
artikel |
11 |
Clinical Trial Modeling and Simulation—Work in Progress
|
Krall, Ronald L. |
|
|
32 |
4 |
p. 971-976 |
artikel |
12 |
Computer System Validation: Value Added Activities Meeting Regulatory Imperatives
|
Woodrum, Tammala D. |
|
|
32 |
4 |
p. 941-945 |
artikel |
13 |
Consumer Preferences for Drug Information after Direct-To-Consumer Advertising
|
Doucette, William R. |
|
|
32 |
4 |
p. 1081-1088 |
artikel |
14 |
Data Capture from the Sponsors’ And Investigators’ Perspectives: Balancing Quality, Speed, and Cost
|
Lampe, Amy J. |
|
|
32 |
4 |
p. 871-886 |
artikel |
15 |
Designing Clinical Trials to Study Rare Disease Treatment
|
Haffner, Marlene E. |
|
|
32 |
4 |
p. 957-960 |
artikel |
16 |
Development and Utilization of a Package Insert Information Retrieval System in the Pharmaceutical Industry
|
Yamamoto, Manai |
|
|
32 |
4 |
p. 1109-1117 |
artikel |
17 |
Driving Forces for Global Technological and Process Change
|
Fitzmartin, Ronald D. |
|
|
32 |
4 |
p. 859-860 |
artikel |
18 |
Drug Review in Canada: A Comparison With Australia, Sweden, the United Kingdom, and the United States
|
Rawson, Nigel S. B. |
|
|
32 |
4 |
p. 1133-1141 |
artikel |
19 |
Dual Energy X-Ray Absorptiometry (DXA) Transmission Methodology in Clinical Trials
|
Miller, Colin G. |
|
|
32 |
4 |
p. 1165-1168 |
artikel |
20 |
Electronic Labeling: A Paperless Future?
|
Martin, Irwin G. |
|
|
32 |
4 |
p. 917-919 |
artikel |
21 |
Guest Editor’s Note: Second Annual Symposium on Osteoporosis Education—Focusing on Behavioral Change
|
Giovenella, Albert J. |
|
|
32 |
4 |
p. 981-984 |
artikel |
22 |
Information Technology Costs and Productivity Gains
|
Woods, William W. |
|
|
32 |
4 |
p. 947-953 |
artikel |
23 |
International Conference on Harmonization-Good Clinical Practices Update
|
Barton, Bette L. |
|
|
32 |
4 |
p. 1143-1147 |
artikel |
24 |
Introduction to Improving Clinical Trials: Contemporary Design Solutions Including Endpoints, Surrogate Comparators, Project Planning, and Computer-Assisted Trial Design (CATD)
|
Olson, Camilla M. |
|
|
32 |
4 |
p. 955-956 |
artikel |
25 |
Osteoporosis and Related Diseases: Voluntary Organizations
|
Galsworthy, Theresa D. |
|
|
32 |
4 |
p. 991-996 |
artikel |
26 |
Report of the Council on Scientific Affairs: Unlabeled Indications of Food and Drug Administration-Approved Drugs
|
Cranston, Joseph W. |
|
|
32 |
4 |
p. 1049-1061 |
artikel |
27 |
The Changing Face of Electronic Data Capture: From Remote Data Entry to Direct Data Capture
|
Hyde, Andrew William |
|
|
32 |
4 |
p. 1089-1092 |
artikel |
28 |
The CIOMS III Criteria for Labeling Changes: A Survey at Schering-Plough
|
Cobert, Barton L. |
|
|
32 |
4 |
p. 1149-1151 |
artikel |
29 |
The Development Of Performance Standards for Medical Communications Personnel
|
Manifold, Carol |
|
|
32 |
4 |
p. 1093-1107 |
artikel |
30 |
The Elegant Machine: Applying Technology to Optimize Clinical Trials
|
Kubick, Wayne R. |
|
|
32 |
4 |
p. 861-869 |
artikel |
31 |
The Future of Medical Education on the Internet
|
Stern, Lawrence S. |
|
|
32 |
4 |
p. 997-1004 |
artikel |
32 |
The Phenytoin Trial is a Case Study of ‘Individual’ Bioequivalence
|
Shumaker, R. C. |
|
|
32 |
4 |
p. 1063-1072 |
artikel |
33 |
The Role of Education in Maintaining a Healthy Society
|
Adler, Madeleine Wing |
|
|
32 |
4 |
p. 985-990 |
artikel |
34 |
The Role of Simulation in The Management of Research: What Can The Pharmaceutical Industry Learn from The Aerospace Industry?
|
Johnson, Shawn C. D. |
|
|
32 |
4 |
p. 961-969 |
artikel |
35 |
Three Topics Integral to the Use of the Internet for Clinical Trials: Connectivity, Communication, and Security
|
Hopp, David I. |
|
|
32 |
4 |
p. 933-939 |
artikel |
36 |
Use of a Remote Computerized System for Study Documentation in Clinical Trials
|
Jones, Mark S. |
|
|
32 |
4 |
p. 1153-1163 |
artikel |
37 |
Using Programming and Database Standards to Promote Efficiency
|
Meimei, J. |
|
|
32 |
4 |
p. 897-904 |
artikel |
38 |
Using the Internet to Report Remaining Lifetime Fracture Probability
|
Wasnich, R. D. |
|
|
32 |
4 |
p. 1005-1010 |
artikel |